Dr Srinivas Pathapati, MD | |
6833 Plum Creek Dr, Amarillo, TX 79124-1602 | |
(806) 467-9820 | |
(806) 468-8340 |
Full Name | Dr Srinivas Pathapati |
---|---|
Gender | Male |
Speciality | Gastroenterology |
Experience | 34 Years |
Location | 6833 Plum Creek Dr, Amarillo, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1124025374 | NPI | - | NPPES |
0066QV | Other | TX | BCBS PROVIDER GRP. NO |
160272401 | Medicaid | TX | |
00568U | Other | TX | MEDICARE GROUP PIN |
8AJ983 | Other | TX | BCBS PROVIDER NO. |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RG0100X | Internal Medicine - Gastroenterology | K9386 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Northwest Texas Hospital | Amarillo, TX | Hospital |
Baptist St Anthony's Hospital | Amarillo, TX | Hospital |
Quail Creek Surgical Hospital | Amarillo, TX | Hospital |
Shannon Medical Center | San angelo, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Texas Digestive Disease Consultants Pllc | 3375531379 | 544 |
News Archive
Childhood cancers are fortunately rare, but among them, neuroblastoma is a special case, accounting for 7 percent of all childhood cancers, but 15 percent of childhood cancer deaths.
In a recent bioRxiv* preprint paper, researchers from the United States demonstrate the pivotal role the furin cleavage site insertion in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike glycoprotein plays in viral replication and pathogenesis – highlighting, in turn, the need for mutation monitoring when developing therapeutics and vaccines.
Artificial intelligence technology developed by the RIKEN Center for Advanced Intelligence Project in Japan has successfully found features in pathology images from human cancer patients, without annotation, that could be understood by human doctors.
Transcept Pharmaceuticals, Inc. today announced that it is scheduled to meet with the U.S. Food and Drug Administration (FDA) on January 20, 2010 to discuss the Complete Response Letter regarding the New Drug Application (NDA) for Intermezzo® (zolpidem tartrate sublingual tablet). As previously announced, the Complete Response Letter, received by Transcept on October 28, 2009, indicated that the FDA could not approve the NDA in its present form.
› Verified 8 days ago
Entity Name | Texas Digestive Disease Consultants Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1053397331 PECOS PAC ID: 3375531379 Enrollment ID: O20040505001844 |
News Archive
Childhood cancers are fortunately rare, but among them, neuroblastoma is a special case, accounting for 7 percent of all childhood cancers, but 15 percent of childhood cancer deaths.
In a recent bioRxiv* preprint paper, researchers from the United States demonstrate the pivotal role the furin cleavage site insertion in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike glycoprotein plays in viral replication and pathogenesis – highlighting, in turn, the need for mutation monitoring when developing therapeutics and vaccines.
Artificial intelligence technology developed by the RIKEN Center for Advanced Intelligence Project in Japan has successfully found features in pathology images from human cancer patients, without annotation, that could be understood by human doctors.
Transcept Pharmaceuticals, Inc. today announced that it is scheduled to meet with the U.S. Food and Drug Administration (FDA) on January 20, 2010 to discuss the Complete Response Letter regarding the New Drug Application (NDA) for Intermezzo® (zolpidem tartrate sublingual tablet). As previously announced, the Complete Response Letter, received by Transcept on October 28, 2009, indicated that the FDA could not approve the NDA in its present form.
› Verified 8 days ago
Entity Name | Panhandle Anesthesia Services, Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1477908408 PECOS PAC ID: 7911299342 Enrollment ID: O20160706000389 |
News Archive
Childhood cancers are fortunately rare, but among them, neuroblastoma is a special case, accounting for 7 percent of all childhood cancers, but 15 percent of childhood cancer deaths.
In a recent bioRxiv* preprint paper, researchers from the United States demonstrate the pivotal role the furin cleavage site insertion in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike glycoprotein plays in viral replication and pathogenesis – highlighting, in turn, the need for mutation monitoring when developing therapeutics and vaccines.
Artificial intelligence technology developed by the RIKEN Center for Advanced Intelligence Project in Japan has successfully found features in pathology images from human cancer patients, without annotation, that could be understood by human doctors.
Transcept Pharmaceuticals, Inc. today announced that it is scheduled to meet with the U.S. Food and Drug Administration (FDA) on January 20, 2010 to discuss the Complete Response Letter regarding the New Drug Application (NDA) for Intermezzo® (zolpidem tartrate sublingual tablet). As previously announced, the Complete Response Letter, received by Transcept on October 28, 2009, indicated that the FDA could not approve the NDA in its present form.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Srinivas Pathapati, MD 6833 Plum Creek Drive, Amarillo, TX 79124-1602 Ph: (806) 467-9820 | Dr Srinivas Pathapati, MD 6833 Plum Creek Dr, Amarillo, TX 79124-1602 Ph: (806) 467-9820 |
News Archive
Childhood cancers are fortunately rare, but among them, neuroblastoma is a special case, accounting for 7 percent of all childhood cancers, but 15 percent of childhood cancer deaths.
In a recent bioRxiv* preprint paper, researchers from the United States demonstrate the pivotal role the furin cleavage site insertion in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike glycoprotein plays in viral replication and pathogenesis – highlighting, in turn, the need for mutation monitoring when developing therapeutics and vaccines.
Artificial intelligence technology developed by the RIKEN Center for Advanced Intelligence Project in Japan has successfully found features in pathology images from human cancer patients, without annotation, that could be understood by human doctors.
Transcept Pharmaceuticals, Inc. today announced that it is scheduled to meet with the U.S. Food and Drug Administration (FDA) on January 20, 2010 to discuss the Complete Response Letter regarding the New Drug Application (NDA) for Intermezzo® (zolpidem tartrate sublingual tablet). As previously announced, the Complete Response Letter, received by Transcept on October 28, 2009, indicated that the FDA could not approve the NDA in its present form.
› Verified 8 days ago
James Edward Lusby, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 6700 W 9th Ave, Amarillo, TX 79106 Phone: 806-358-0200 Fax: 806-356-5590 | |
Henry David Bruton, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 6700 W 9th Ave, Amarillo, TX 79106 Phone: 806-358-0200 Fax: 806-356-5511 | |
Dr. Anjali Subhash Kherdekar, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 12 Care Cir, Amarillo, TX 79124 Phone: 806-353-7417 Fax: 806-353-4007 | |
James P.a. Yhip, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1660 Point West Pkwy, Amarillo, TX 79124 Phone: 806-510-4244 Fax: 806-510-7211 | |
Dr. Michael John Lamanteer, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 1600 Wallace Blvd, Amarillo, TX 79106 Phone: 806-212-2129 Fax: 806-212-2246 | |
Thien Toan Vo, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1400 S Coulter St, Amarillo, TX 79106 Phone: 806-414-9100 Fax: 806-354-5717 | |
John Scott Milton, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 1400 S Coulter St, Amarillo, TX 79106 Phone: 806-354-5480 Fax: 806-354-5764 |